Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 166

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Transcatheter Valve Repair for Patients With Mitral Regurgitation

Open access
Lim, D. Scott, Kar, Saibal, Spargias, Konstantinos, Kipperman, Robert M., O’Neill, William W., Ng, Martin K.C., Fam, Neil P., Walters, Darren L., Webb, John G., Smith, Robert L., Rinaldi, Michael J., Latib, Azeem, Cohen, Gideon N., Schäfer, Ulrich, Marcoff, Leo, Vandrangi, Prashanthi, Verta, Patrick, Feldman, Ted E. · 2019 · JACC: Cardiovascular Interventions

Abstract

OBJECTIVES The authors report the procedural and 30-day results of the PASCAL Transcatheter Valve Repair System (Edwards Lifesciences, Irvine, California) in patients with mitral regurgitation (MR) enrolled in the multicenter, prospective, single-arm CLASP study. BACKGROUND Severe MR may lead to symptoms, impaired quality of life, and reduced functional capacity when untreated. METHODS Eligible patients had grade 3+ or 4+ MR despite optimal medical therapy and were deemed appropriate for the study by the local heart team. All outcomes were assessed through 30 days post-procedure. Major adverse events (MAEs) were adjudicated by an independent clinical events committee, and echocardiographic images were assessed by a core laboratory. The primary safety endpoint was the rate of MAEs at 30 days. RESULTS Between June 2017 and September 2018, 62 patients with grade 3+ or 4+ MR were enrolled. The mean age was 76.5 years, and 51.6% of patients were in New York Heart Association functional class III or IV, with 56% functional, 36% degenerative, and 8% mixed MR etiology. At 30 days, the MAE rate was 6.5%, with an all-cause mortality rate of 1.6% and no occurrence of stroke; 98% had MR grade ≤2+, with 86% with MR grade ≤1+ (p < 0.0001); and 85% were in New York Heart Association functional class I or II (p < 0.0001). Six-minute walk distance improved by 36 m (p = 0.0018), and Kansas City Cardiomyopathy Questionnaire and EQ-5D scores improved by 17 (p < 0.0001) and 10 (p = 0.0004) points, respectively. CONCLUSIONS The PASCAL repair system showed feasibility and acceptable safety in the treatment of patients with grade 3+ or 4+ MR. MR severity, irrespective of etiology, was significantly reduced and accompanied by clinically and statistically significant improvements in functional status, exercise capacity, and quality of life. (The CLASP Study Edwards PASCAL Transcatheter Mitral Valve Repair System Study; NCT03170349).

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jcin.2019.04.034

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 166

Metadata

Authors
Lim, D. S., Kar, S., Spargias, K., Kipperman, R. M., O’Neill, W. W., Ng, M. K. C., Fam, N. P., Walters, D. L., Webb, J. G., Smith, R. L., Rinaldi, M. J., Latib, A., Cohen, G. N., Schäfer, U., Marcoff, L., Vandrangi, P., Verta, P., & Feldman, T. E.
Venue
JACC: Cardiovascular Interventions
Publisher
Elsevier BV
Published
2019-07
Volume
12
Issue
14
Pages
1369-1378
ISSN
  • 1876-7605 (ISSN-L)
  • 1936-8798
OpenAlex
W2955640716
Cited by
166
References
2
FWCI
17.93
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Transcatheter Valve Repair for Patients With Mitral Regurgitation. https://app.cochat.ai/papers/10.1016/j.jcin.2019.04.034
The paper
Lim, D. S., Kar, S., Spargias, K., Kipperman, R. M., O’Neill, W. W., Ng, M. K. C., Fam, N. P., Walters, D. L., Webb, J. G., Smith, R. L., Rinaldi, M. J., Latib, A., Cohen, G. N., Schäfer, U., Marcoff, L., Vandrangi, P., Verta, P., & Feldman, T. E. (2019). Transcatheter Valve Repair for Patients With Mitral Regurgitation. JACC: Cardiovascular Interventions. https://doi.org/10.1016/j.jcin.2019.04.034

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.